Fortress Biotech, Inc.
FBIOHealthcare|Biotechnology|US
$1.85
+0.01 (+0.54%)
Tangible Book / Share
$5.70
Graham Number
$20.29
Cash / Share
$6.21
Ownership Breakdown
69.1%
Float
33.4M
Shares Outstanding
23.0M
Float Shares
Major Holders (6)
Combined: 54.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | Individual | 20.70% | 6,917,715 | Mar 20, 2026 | 13D/G |
| Highbridge Capital Management, LLC | IA, OO | 7.80% | 2,734,654 | May 15, 2026 | 13D/G |
| Millennium Management LLC | Other | 6.50% | 2,165,401 | Oct 29, 2026 | 13D/G |
| Israel A. Englander | Individual | 6.50% | 2,165,401 | Oct 29, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 6.50% | 2,165,401 | Oct 29, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 6.50% | 2,165,122 | Oct 29, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,494,326 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jin David | Chief Financial Officer | Oct 1, 2026 | AWARD | 1,190 | $1.82 | $2.2K | Form 4 |
| Jin David | Chief Financial Officer | Jun 22, 2026 | AWARD | 400,000 | — | — | Form 4 |
| Jin David | Chief Financial Officer | Apr 1, 2026 | AWARD | 2,967 | $2.18 | $6.5K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Mar 18, 2026 | AWARD | 475,424 | — | — | Form 4 |
| WEISS MICHAEL S | director, officer: Executive Vice Chairman | Mar 18, 2026 | AWARD | 475,424 | — | — | Form 4 |
| Klein Dov | director | Jan 1, 2026 | AWARD | 27,322 | — | — | Form 4 |
| Harvey Jimmie | director | Jan 1, 2026 | AWARD | 27,322 | — | — | Form 4 |
| Lorenz Kevin | director | Jan 1, 2026 | AWARD | 27,322 | — | — | Form 4 |
| Hoenlein Malcolm | director | Jan 1, 2026 | AWARD | 27,322 | — | — | Form 4 |
| LOBELL J JAY | director | Jan 1, 2026 | AWARD | 27,322 | — | — | Form 4 |
| Jin David | Chief Financial Officer | Oct 1, 2025 | AWARD | 2,711 | $1.31 | $3.5K | Form 4 |
| Jin David | Chief Financial Officer | Apr 1, 2025 | AWARD | 5,000 | $1.22 | $6.1K | Form 4 |
| Klein Dov | director | Jan 1, 2025 | AWARD | 49,383 | — | — | Form 4 |
| Lu Lucy | director | Jan 1, 2025 | AWARD | 49,383 | — | — | Form 4 |
| Harvey Jimmie | director | Jan 1, 2025 | AWARD | 49,383 | — | — | Form 4 |
| Lorenz Kevin | director | Jan 1, 2025 | AWARD | 49,383 | — | — | Form 4 |
| Hoenlein Malcolm | director | Jan 1, 2025 | AWARD | 49,383 | — | — | Form 4 |
| WEISS MICHAEL S | director, officer: Executive Vice Chairman | Jan 1, 2025 | AWARD | 454,153 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Jan 1, 2025 | AWARD | 454,153 | — | — | Form 4 |
| Jin David | Chief Financial Officer | Dec 19, 2024 | AWARD | 1,000,000 | — | — | Form 4 |
| Jin David | Chief Financial Officer | Oct 1, 2024 | AWARD | 2,625 | $1.23 | $3.2K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Sep 23, 2024 | BUY | 763,359 | $1.84 | $1.4M | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Sep 23, 2024 | BUY | 763,359 | $1.84 | $1.4M | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jul 11, 2024 | BUY | 5,000 | $7.48 | $37.4K | Form 4 |
| Jin David | Chief Financial Officer | Jul 10, 2024 | BUY | 500 | $7.50 | $3.8K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jul 9, 2024 | BUY | 5,000 | $7.39 | $37.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jul 8, 2024 | BUY | 5,000 | $7.35 | $36.8K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jun 28, 2024 | BUY | 20,000 | $1.64 | $32.7K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | May 16, 2024 | BUY | 10,000 | $1.76 | $17.6K | Form 4 |
| Klein Dov | director | May 20, 2024 | SELL | 10,000 | $1.89 | $18.9K | Form 4 |
| Jin David | Chief Financial Officer | Apr 1, 2024 | AWARD | 2,352 | $1.70 | $4.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jan 5, 2024 | BUY | 50,000 | $2.38 | $118.8K | Form 4 |
| Lu Lucy | director | Jan 1, 2024 | AWARD | 3,333 | — | — | Form 4 |
| Lorenz Kevin | director | Jan 1, 2024 | AWARD | 3,333 | — | — | Form 4 |
| LOBELL J JAY | director | Jan 1, 2024 | AWARD | 6,666 | — | — | Form 4 |
| Klein Dov | director | Jan 1, 2024 | AWARD | 6,666 | — | — | Form 4 |
| Hoenlein Malcolm | director | Jan 1, 2024 | AWARD | 3,333 | — | — | Form 4 |
| Harvey Jimmie | director | Jan 1, 2024 | AWARD | 6,666 | — | — | Form 4 |
| WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | Jan 1, 2024 | AWARD | 216,465 | — | — | Form 4 |
| Rowinsky Eric K | director | Jan 1, 2024 | AWARD | 6,666 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Jan 1, 2024 | AWARD | 216,465 | — | — | Form 4 |
| Jin David | Chief Financial Officer | Dec 20, 2023 | AWARD | 140,000 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Nov 14, 2023 | BUY | 1,567,515 | $1.70 | $2.7M | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Nov 14, 2023 | BUY | 1,567,515 | $1.70 | $2.7M | Form 4 |
| WEISS MICHAEL S | director, officer: See Remarks | Nov 14, 2023 | BUY | 147,058 | $1.70 | $250.0K | Form 4 |
| WEISS MICHAEL S | director, officer: See Remarks | Nov 14, 2023 | BUY | 147,058 | $1.70 | $250.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Sep 26, 2023 | BUY | 100,000 | $0.28 | $28.3K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Aug 18, 2023 | BUY | 10,000 | $9.34 | $93.4K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Aug 17, 2023 | BUY | 10,000 | $11.75 | $117.5K | Form 4 |
| WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | Feb 10, 2023 | BUY | 1,197,604 | $0.83 | $1000.0K | Form 4 |
| Rowinsky Eric K | director | Feb 10, 2023 | BUY | 11,976 | $0.83 | $10.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | Feb 10, 2023 | BUY | 2,395,209 | $0.83 | $2.0M | Form 4 |
| Lu Lucy | director | Feb 10, 2023 | BUY | 11,976 | $0.83 | $10.0K | Form 4 |
| LOBELL J JAY | director | Feb 10, 2023 | BUY | 299,401 | $0.83 | $250.0K | Form 4 |
| Jin David | Chief Financial Officer | Feb 10, 2023 | BUY | 35,928 | $0.83 | $30.0K | Form 4 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman | Jan 1, 2023 | AWARD | 1,219,294 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | President, CEO & Chairman | Jun 1, 2022 | AWARD | 4,264 | $0.73 | $3.1K | Form 4 |
| Lu Lucy | director | Jan 1, 2023 | AWARD | 50,000 | — | — | Form 4 |
| WEISS MICHAEL S | See Remarks | Jan 1, 2023 | AWARD | 1,219,294 | — | — | Form 4 |
| Rowinsky Eric K | director | Jan 1, 2023 | AWARD | 100,000 | — | — | Form 4 |
| Lorenz Kevin | director | Jan 1, 2023 | AWARD | 50,000 | — | — | Form 4 |
| LOBELL J JAY | director | Jan 1, 2023 | AWARD | 100,000 | — | — | Form 4 |
| Klein Dov | director | Jan 1, 2023 | AWARD | 100,000 | — | — | Form 4 |
| Hoenlein Malcolm | director | Jan 1, 2023 | AWARD | 50,000 | — | — | Form 4 |
| Harvey Jimmie | director | Jan 1, 2023 | AWARD | 100,000 | — | — | Form 4 |
| Lu Lucy | director | Dec 16, 2022 | AWARD | 30,000 | — | — | Form 4 |
| Lu Lucy | director | Dec 14, 2022 | DISPOSED | 0 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Dec 1, 2022 | BUY | 100,000 | $0.68 | $68.0K | Form 4 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Nov 30, 2022 | BUY | 5,000 | $0.56 | $2.8K | Form 4 |
| Jin David | Chief Financial Officer | Nov 30, 2022 | BUY | 5,000 | $0.56 | $2.8K | Form 4 |
| Jin David | Chief Financial Officer | Oct 26, 2022 | AWARD | 1,350,000 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | Oct 21, 2022 | BUY | 100,000 | $0.69 | $69.5K | Form 4 |
| Jin David | Chief Financial Officer | Aug 16, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Klein Dov | director | Jan 1, 2022 | AWARD | 100,000 | — | — | Form 4 |
| Klein Dov | director | Nov 16, 2021 | J | 230 | — | — | Form 4 |
| Klein Dov | director | Sep 30, 2021 | J | 480 | — | — | Form 4 |
| Klein Dov | director | Aug 5, 2021 | J | 305 | — | — | Form 4 |
| Klein Dov | director | Dec 28, 2021 | SELL | 5,000 | $2.45 | $12.3K | Form 4 |
| Hunter Robyn | Chief Financial Officer | Sep 21, 2021 | SELL | 28,292 | $3.13 | $88.6K | Form 4 |
| WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | Jan 1, 2022 | AWARD | 1,102,986 | — | — | Form 4 |
| Hoenlein Malcolm | director | Jan 1, 2022 | AWARD | 50,000 | — | — | Form 4 |
| Hoenlein Malcolm | director | Nov 16, 2021 | J | 230 | — | — | Form 4 |
| Hoenlein Malcolm | director | Sep 30, 2021 | J | 406 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Jan 1, 2022 | AWARD | 1,102,986 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Dec 1, 2021 | AWARD | 1,250 | $2.42 | $3.0K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Nov 16, 2021 | J | 4,619 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Sep 30, 2021 | J | 8,133 | — | — | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Jun 1, 2021 | AWARD | 1,297 | $2.31 | $3.0K | Form 4 |
| Lorenz Kevin | director | Jan 1, 2022 | AWARD | 50,000 | — | — | Form 4 |
| Harvey Jimmie | director | Jan 1, 2022 | AWARD | 100,000 | — | — | Form 4 |
| LOBELL J JAY | director | Jan 1, 2022 | AWARD | 100,000 | — | — | Form 4 |
| Rowinsky Eric K | director | Jan 1, 2022 | AWARD | 100,000 | — | — | Form 4 |
| WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | Jan 1, 2021 | AWARD | 1,030,339 | — | — | Form 4 |
| Rowinsky Eric K | director | Jan 1, 2021 | AWARD | 100,000 | — | — | Form 4 |
| Rowinsky Eric K | director | Feb 5, 2021 | SELL | 4,000 | $3.80 | $15.2K | Form 4 |
| Rowinsky Eric K | director | Feb 16, 2021 | SELL | 2,000 | $3.86 | $7.7K | Form 4 |
| Rowinsky Eric K | director | Feb 18, 2021 | SELL | 6,000 | $4.20 | $25.2K | Form 4 |
| Rowinsky Eric K | director | Feb 19, 2021 | SELL | 8,000 | $4.31 | $34.5K | Form 4 |
| Rowinsky Eric K | director | Mar 2, 2021 | SELL | 10,000 | $4.45 | $44.5K | Form 4 |
| ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: PRESIDENT, CEO & CHAIRMAN | Jan 1, 2021 | AWARD | 1,030,339 | — | — | Form 4 |